"Bacterial Toxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
| Descriptor ID |
D001427
|
| MeSH Number(s) |
D23.946.123
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bacterial Toxins".
Below are MeSH descriptors whose meaning is more specific than "Bacterial Toxins".
This graph shows the total number of publications written about "Bacterial Toxins" by people in this website by year, and whether "Bacterial Toxins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 3 | 1 | 4 |
| 1996 | 3 | 0 | 3 |
| 1997 | 5 | 0 | 5 |
| 1998 | 5 | 1 | 6 |
| 1999 | 5 | 1 | 6 |
| 2000 | 6 | 0 | 6 |
| 2001 | 5 | 1 | 6 |
| 2002 | 6 | 1 | 7 |
| 2003 | 4 | 1 | 5 |
| 2004 | 3 | 1 | 4 |
| 2005 | 8 | 3 | 11 |
| 2006 | 6 | 0 | 6 |
| 2007 | 5 | 0 | 5 |
| 2008 | 3 | 0 | 3 |
| 2009 | 5 | 1 | 6 |
| 2010 | 4 | 2 | 6 |
| 2011 | 8 | 0 | 8 |
| 2012 | 6 | 0 | 6 |
| 2013 | 4 | 2 | 6 |
| 2014 | 1 | 0 | 1 |
| 2015 | 5 | 1 | 6 |
| 2016 | 5 | 0 | 5 |
| 2017 | 5 | 0 | 5 |
| 2018 | 1 | 0 | 1 |
| 2019 | 5 | 3 | 8 |
| 2020 | 5 | 1 | 6 |
| 2021 | 4 | 1 | 5 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bacterial Toxins" by people in Profiles.
-
Mycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs. Nat Commun. 2024 Jun 27; 15(1):5467.
-
A sequence invariable region in TcdB2 is required for toxin escape from Clostridioides difficile. J Bacteriol. 2024 07 25; 206(7):e0009624.
-
Distant relatives of a eukaryotic cell-specific toxin family evolved a complement-like mechanism to kill bacteria. Nat Commun. 2024 Jun 12; 15(1):5028.
-
Clostridioides difficile toxin B subverts germinal center and antibody recall responses by stimulating a drug-treatable CXCR4-dependent mechanism. Cell Rep. 2024 May 28; 43(5):114245.
-
Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease. PLoS Pathog. 2023 03; 19(3):e1011272.
-
Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes. Infect Immun. 2022 04 21; 90(4):e0007322.
-
Group 3 innate lymphocytes (ILC3s) upregulate IL-22 in response to elevated intracellular cAMP levels. Cytokine. 2022 05; 153:155862.
-
Hydrogen-Deuterium Exchange Mass Spectrometry Reveals a Novel Binding Region of a Neutralizing Fully Human Monoclonal Antibody to Anthrax Protective Antigen. Toxins (Basel). 2022 01 25; 14(2).
-
ParD Antitoxin Hotspot Alters a Disorder-to-Order Transition upon Binding to Its Cognate ParE Toxin, Lessening Its Interaction Affinity and Increasing Its Protease Degradation Kinetics. Biochemistry. 2022 01 04; 61(1):34-45.
-
The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility. Infect Immun. 2021 09 16; 89(10):e0027421.